Agenix: Patent In Japan for Diagnostic Technology
Agenix Limited announced that Japan's Patent Office had granted a key patent covering the manufacturing process of its ThromboView® imaging agent for the detection of blood clots in humans.
Agenix Chairman and Chief Executive Officer, Nicholas Weston said, "The granting of patent protection in Japan confers further certainty and significantly increases the commercial value of the ThromboView diagnostic technology globally. In conjunction with the other patents covering the use and production of ThromboView, this new patent delivers a major commercial advantage to Agenix in one of the world's leading markets for diagnostic imaging and manufacturing.”
Japanese Patent Application Number 2003-507139 covers humanized antibodies derived from DD-3B6/22 specific for the D-dimer fragment of fibrin provides long-term protection for the company's technology through broad claims over methods of manufacture and use.
ThromboView is now protected by multiple patents in the Japan, the United States, Europe, Singapore, Australia and New Zealand, with the granting of patents for China and Canada pending. The patents provide protection for ThromboView out to 2022 with possible Hatch-Waxman term extension out to 2027.
- blood clotting
- diagnostic tests
- imaging agents
- 1analytica 2016: Record number of exhibitors thanks to 6.5 percent increase
- 2Schleicher & Schuell has been purchased by Whatman plc
- 3analytica 2016: Key platform for upcoming scientists
- 4The latest technologies in food and plastics analysis, bioanalysis and genetic analysis
- 5Electronic device detects molecules linked to cancer, Alzheimer's and Parkinson's
- 6Eurofins reinforces its environment testing footprint with the acquisition of EAC Corp. in Japan
- 7Laboratory of the future at analytica in Munich in the present
- 8SCHOTT Is Now a Stock Corporation
- 9Beijing Higher Court rules in favor of Merck Millipore in patent infringement case
- 10Device may provide rapid diagnosis of bacterial infections
- Thermal modification of wood and a complex study of its properties by magnet ...
- Engineers take first step toward flexible, wearable, tricoder-like device
- Nanotubes are beacons in cancer-imaging technique
- More light on cancer
- Electronic device detects molecules linked to cancer, Alzheimer's and Parkin ...